Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2001 1
2002 3
2003 3
2005 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
ST depression in ECG at entry indicates severe coronary lesions and large benefits of an early invasive treatment strategy in unstable coronary artery disease; the FRISC II ECG substudy. The Fast Revascularisation during InStability in Coronary artery disease.
Diderholm E, Andrén B, Frostfeldt G, Genberg M, Jernberg T, Lagerqvist B, Lindahl B, Wallentin L 2nd. Diderholm E, et al. Among authors: frostfeldt g. Eur Heart J. 2002 Jan;23(1):41-9. doi: 10.1053/euhj.2001.2694. Eur Heart J. 2002. PMID: 11741361 Clinical Trial.
The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy.
Diderholm E, Andrén B, Frostfeldt G, Genberg M, Jernberg T, Lagerqvist B, Lindahl B, Venge P, Wallentin L; Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators. Diderholm E, et al. Among authors: frostfeldt g. Am Heart J. 2002 May;143(5):760-7. doi: 10.1067/mhj.2002.121733. Am Heart J. 2002. PMID: 12040335 Clinical Trial.
Low molecular weight heparin (dalteparin) as adjuvant treatment of thrombolysis in acute myocardial infarction--a pilot study: biochemical markers in acute coronary syndromes (BIOMACS II).
Frostfeldt G, Ahlberg G, Gustafsson G, Helmius G, Lindahl B, Nygren A, Siegbahn A, Swahn E, Venge P, Wallentin L. Frostfeldt G, et al. J Am Coll Cardiol. 1999 Mar;33(3):627-33. doi: 10.1016/s0735-1097(98)00612-3. J Am Coll Cardiol. 1999. PMID: 10080461 Free article. Clinical Trial.